Abiopharma

News list

Riley Antony A 🟢 acquired 22.0K shares (1 derivative) of Forte Biosciences, Inc. (FBRX) at $17.15 Transaction Date: Jun 16, 2026 | Filing ID: 000008

Full text

News bot June 17, 2026, 8:56 p.m.
🔍 Riley Antony A (Executive)

Company: Forte Biosciences, Inc. (FBRX)

Report Date: 2026-06-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 22,000
Detailed Transactions and Holdings:
- Acquired 22,000 shares of Stock Option (right to buy) at $17.15 per share (Derivative)
  Date: 2026-06-16 | Code: A | Expires: 2036-06-16 | equity_swap_involved: 0 | shares_owned_after: 22,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 16, 2026.